Rate My Professor Daniel Malone

Malone's research focuses on pharmacy education, assessment, and case-based learning, with contributions to UN Sustainable Development Goals in good health and quality education. Key publications include 'Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models' (2010), 'Cannabidiol reverses MK-801-induced disruption of prepulse inhibition in mice' (2006), 'Biased agonism and biased allosteric modulation at the CB1 cannabinoid receptor' (2015), 'How do interruptions and distractions affect pharmacy practice? A scoping review' (2025), and 'Substitution of a Traditional Face-to-Face Workshop with Virtual Escape Room in Higher Education' (2025). He has received the American Associated Colleges of Pharmacy Innovation in Teaching Award (2022), Monash Education Excellence: Teaching Excellence (2022), Excellence in Teaching: Programs that Enhance Student Learning (2015), Office of Learning & Teaching Citation for Outstanding Contributions to Student Learning (2012), and a 2024 program award recognition. Malone serves on the Examinations Committee (since 2019) and Accreditation Assessment Team (since 2023) of the Australian Pharmacy Council, and contributes media commentary on health topics.